Levomilnacipran
Showing 1 - 25 of 58
None (i.e. Healthy Volunteers) Trial in Ottawa (Levomilnacipran, Duloxetine, Placebos)
Active, not recruiting
- None (i.e. Healthy Volunteers)
- Levomilnacipran
- +2 more
-
Ottawa, Ontario, CanadaInstitute of Mental Health Research, Royal Ottawa Mental Health
Oct 5, 2021
MDD Trial in Pittsburgh (Escitalopram Pill, Placebo, Levomilnacipran Pill)
Recruiting
- Major Depressive Disorder
- Escitalopram Pill
- +2 more
-
Pittsburgh, PennsylvaniaUniversity of Pittsburgh
Dec 1, 2022
MDD Trial in United States (Levomilnacipran ER, Fluoxetine, Placebo)
Completed
- Major Depressive Disorder
- Levomilnacipran ER
- +2 more
-
Little Rock, Arkansas
- +50 more
Mar 1, 2022
MDD Trial in Puerto Rico, United States (Placebo, Levomilnacipran, Fluoxetine)
Completed
- Major Depressive Disorder
- Placebo
- +2 more
-
Dothan, Alabama
- +48 more
Aug 19, 2020
MDD Trial in Los Angeles (levomilnacipran, Placebo)
Completed
- Major Depressive Disorder
- levomilnacipran
- Placebo
-
Los Angeles, CaliforniaUCLA Semel Institute - Neuropsychiatric Institute (NPI)
Aug 2, 2019
MDD Trial in Alpharetta (Levomilnacipran, Quetiapine)
Completed
- Major Depressive Disorder
- Levomilnacipran
- Quetiapine
-
Alpharetta, GeorgiaInstitute for Advanced Medical Research
Aug 2, 2019
Depression, MDD Trial in Canada, United States (Levomilnacipran ER, Placebo)
Completed
- Depression
- Major Depressive Disorder
- Levomilnacipran ER
- Placebo
-
Beverly Hills, California
- +34 more
Dec 23, 2019
Fibromyalgia Trial in Mansoura (Milnacipran, Gabapentin, Combined gabapentin/milnacipran)
Enrolling by invitation
- Fibromyalgia
- Milnacipran
- +2 more
-
Mansoura, DK, EgyptMansoura University
May 17, 2022
Post Treatment Lyme Syndrome (PTLS), Chronic Pain Trial in New York (Milnacipran and D-cycloserine)
Terminated
- Post Treatment Lyme Syndrome
- +2 more
- Milnacipran with D-cycloserine augmentation
- Milnacipran with placebo augmentation
- (no location specified)
Sep 14, 2021
Depressive Disorder, Major Trial in United States (Levomilnacipran ER, Placebo)
Completed
- Depressive Disorder, Major
- Levomilnacipran ER
- Placebo
-
Birmingham, Alabama
- +46 more
Sep 28, 2018
Idiopathic Peripheral Neuropathy Trial in New York (Milnacipran, Placebo)
Terminated
- Idiopathic Peripheral Neuropathy
- Milnacipran
- Placebo
-
New York, New YorkColumbia University Medical Center
Aug 19, 2020
Post Treatment Lyme Syndrome (PTLS), Chronic Pain Trial in New York (Milnacipran and D-cycloserine)
Terminated
- Post Treatment Lyme Syndrome (PTLS)
- Chronic Pain
- Milnacipran and D-cycloserine
-
New York, New YorkColumbia University Medical Center
May 18, 2020
Fibromyalgia Trial in Albany (Milnacipran, Skin biopsy, Skin Biopsy)
Completed
- Fibromyalgia
- Milnacipran
- +2 more
-
Albany, New YorkUpstate Clinical Research, LLC
Jan 7, 2020
Depressive Disorder, Major Trial in United States (JNJ-42847922, Placebo Matching to JNJ-42847922, Quetiapine XR)
Autism Spectrum Disorder, Asperger Syndrome, Aspergers Syndrome Trial in Bronx (Milnacipran, Placebo)
Completed
- Autism Spectrum Disorder
- +2 more
- Milnacipran
- Placebo
-
Bronx, New YorkMontefiore Medical Center, Albert Einstein College of Medicine
Feb 13, 2020
Neuropathic Pain Trial in Haifa (Morphine, Milnacipran)
Unknown status
- Neuropathic Pain
-
Haifa, IsraelRambam Health Care Campus
Apr 1, 2019
Sleep Disorders, Fibromyalgia, Sleep Trial in Middleburg Heights (Milnacipran, Placebo)
Completed
- Sleep Disorders
- +2 more
- Milnacipran
- Placebo
-
Middleburg Heights, OhioCleveland Sleep Research Center
Aug 7, 2019
Primary Fibromyalgia Trial in United States (Milnacipran, Placebo)
Genecept Assay and Adverse Effects of Antidepressants
Completed
- Depression
- Adverse Effects
- Genocept Assay
-
Philadelphia, PennsylvaniaThomas Jefferson University
Mar 14, 2018
Vestibulodynia, Vulvodynia Trial in Germantown (Milnacipran)
Completed
- Vestibulodynia
- Vulvodynia
-
Germantown, TennesseeWomen's Health Specialists, PLLC
May 9, 2018
Rheumatoid Arthritis Trial in Los Angeles (Milnacipran)
Completed
- Rheumatoid Arthritis
-
Los Angeles, CaliforniaUCLA Semel Institute
Feb 27, 2018
Fibromyalgia Trial in Ann Arbor (milnacipran, Placebo)
Completed
- Fibromyalgia
- milnacipran
- Placebo
-
Ann Arbor, MichiganUniversity of Michigan, Chronic Pain and Fatigue Research Center
Oct 4, 2017
Irritable Bowel Syndrome Trial in Chapel Hill (Milnacipran, Placebo)
Terminated
- Irritable Bowel Syndrome
- Milnacipran
- Placebo
-
Chapel Hill, North CarolinaUNC Center for Functional GI and Motility Disorders
Mar 15, 2017
Back Pain Trial in Chestnut Hill (Savella)
Withdrawn
- Back Pain
-
Chestnut Hill, MassachusettsBrigham and Women's Hospital Pain Trials Center
Jan 11, 2017